In Vitro Activity of Telavancin Against Gram-positive Pathogens, Including Resistant Subsets: Results from a Global Surveillance Program (2007)
In Vitro Activity of Telavancin Against Gram-positive Pathogens, Including Resistant Subsets: Results from a Global Surveillance Program (2007), Lead author: Fritsche TR, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA